发布: 2016年06月20日第6卷第12期 DOI: 10.21769/BioProtoc.1838 浏览次数: 22664
评审: Lee-Hwa TaiMartin V KolevAnonymous reviewer(s)
Abstract
Cytotoxic CD8+ T cells are responsible for the lysis of cells expressing peptides associated with MHC class I molecules and derived from infection with a pathogen or from mutated antigens. In order to quantify in vivo this antigen-specific CD8+ T cell killing activity, we use the in vivo killing assay (IVK). Here we describe the protocol for the lysis of cells expressing a CD8+ T cell epitope of the OVA protein (SIINFEKL). Mice are previously immunized with the OVA protein and 7 days after immunization, they receive a mix of target cells, prepared from naive C57BL/6 spleen cells pulsed with the SIINFEKL peptide and labeled with high level of CFSE and of non-pulsed control cells labeled with low level of CFSE. One day later, the spleen cells of recipient mice are isolated and analyzed by FACS to measure the amount of CFSEhigh cells and CFSElow cells. The percentage of lysis is calculated by the difference between CFSE high versus low in immunized vs non-immunized mice.
Measuring the ability of antigen-specific CD8+ T cell to lyse their antigen in vivo is very important to evaluate the adaptive cytotoxic response induced against a pathogen or a tumor antigen.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2016 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Chaoul, N., Fayolle, C. and Leclerc, C. (2016). In vivo OVA-specific Cytotoxic CD8+ T Cell Killing Assay. Bio-protocol 6(12): e1838. DOI: 10.21769/BioProtoc.1838.
分类
免疫学 > 免疫细胞功能 > 细胞毒性
免疫学 > 免疫细胞功能 > 抗原特异反应
免疫学 > 免疫细胞染色 > 流式细胞术
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link